Literature DB >> 15196216

Induction of nitric oxide release from the human alveolar epithelial cell line A549: an in vitro correlate of innate immune response to Mycobacterium tuberculosis.

Sugata Roy1, Sadhna Sharma, Monika Sharma, Ramesh Aggarwal, Mridula Bose.   

Abstract

In view of the presence of a large number of epithelial cells in the alveoli of the lung and their ability to produce various cytokines and chemokines, the possible role of alveolar epithelial cells in the innate immune response to tuberculosis was examined. The human alveolar epithelial cell line A549 was used as a model. The ability of A549 cells to induce nitric oxide (NO) in response to Mycobacterium tuberculosis infection was taken as an in vitro correlate of innate immunity. M. tuberculosis infection induced A549 cells to produce significant levels of NO and to express inducible nitric oxide synthase mRNA at 48 hr of infection. However, the amount of NO released at this point was not mycobactericidal. Cytokine stimulation (interferon-gamma, tumour necrosis factor-alpha, interleukin-1beta, alone or in combination) of the infected A549 cells induced a higher concentration of NO. The study of colony-forming units (CFU) as a measure of the mycobactericidal capacity of A549 cells revealed a reduction in CFU of M. tuberculosis by 39.29% (from 10.62 +/- 0.48 - 6.392 +/- 0.54) following cytokine stimulation of the infected cells. Interestingly gamma-irradiated M. tuberculosis H37Rv could also induce higher than basal level of NO. Therefore we examined mycobacterial antigenic components for their possible role in NO production. We observed that A549 cells produced significantly higher amounts of NO at 48 hr when treated with mycobacterial whole cell lysates, cell wall or cell membrane preparations. The release of NO and the resultant mycobactericidal activity could be further enhanced by simultaneously conditioning the M. tuberculosis infected A549 cells with cytokine and mycobacterial components. These results suggest that alveolar epithelial cells respond to their microenvironment, which is constituted of various cytokines and macrophage-processed antigens and may contribute to the innate immune response to tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15196216      PMCID: PMC1782514          DOI: 10.1046/j.1365-2567.2004.01905.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  38 in total

1.  Identification of nitric oxide synthase as a protective locus against tuberculosis.

Authors:  J D MacMicking; R J North; R LaCourse; J S Mudgett; S K Shah; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

2.  Macrophage activation revisited.

Authors:  A Celada; C Nathan
Journal:  Immunol Today       Date:  1994-03

3.  Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection.

Authors:  R Hernández-Pando; M Jeyanathan; G Mengistu; D Aguilar; H Orozco; M Harboe; G A Rook; G Bjune
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

4.  Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages.

Authors:  C D Gaynor; F X McCormack; D R Voelker; S E McGowan; L S Schlesinger
Journal:  J Immunol       Date:  1995-12-01       Impact factor: 5.422

5.  Nitric oxide dependent killing of mycobacterium tuberculosis by human mononuclear phagocytes from patients with active tuberculosis.

Authors:  M Bose; P Farnia; S Sharma; D Chattopadhya; K Saha
Journal:  Int J Immunopathol Pharmacol       Date:  1999 May-Aug       Impact factor: 3.219

6.  Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.

Authors:  A H Ding; C F Nathan; D J Stuehr
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

7.  An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT.

Authors:  N W Roehm; G H Rodgers; S M Hatfield; A L Glasebrook
Journal:  J Immunol Methods       Date:  1991-09-13       Impact factor: 2.303

8.  Mycobacterium tuberculosis invades and replicates within type II alveolar cells.

Authors:  L E Bermudez; J Goodman
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

Review 9.  Participation of pulmonary alveolar epithelial cells in lung inflammation.

Authors:  R H Simon; R Paine
Journal:  J Lab Clin Med       Date:  1995-08

10.  Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells.

Authors:  K Asano; C B Chee; B Gaston; C M Lilly; C Gerard; J M Drazen; J S Stamler
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

View more
  22 in total

1.  Interferon-alphabeta mediates partial control of early pulmonary Mycobacterium bovis bacillus Calmette-Guérin infection.

Authors:  John Kuchtey; Scott A Fulton; Scott M Reba; Clifford V Harding; W Henry Boom
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

Review 2.  MR1-restricted mucosal associated invariant T (MAIT) cells in the immune response to Mycobacterium tuberculosis.

Authors:  Marielle C Gold; Ruth J Napier; David M Lewinsohn
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

Review 3.  Mycobacterium tuberculosis infection of the 'non-classical immune cell'.

Authors:  Philippa J Randall; Nai-Jen Hsu; Valerie Quesniaux; Bernhard Ryffel; Muazzam Jacobs
Journal:  Immunol Cell Biol       Date:  2015-03-24       Impact factor: 5.126

4.  Interaction of alveolar epithelial cells with CFP21, a mycobacterial cutinase-like enzyme.

Authors:  Pooja Vir; Dheeraj Gupta; Ritesh Agarwal; Indu Verma
Journal:  Mol Cell Biochem       Date:  2014-08-05       Impact factor: 3.396

5.  Natural lysophospholipids reduce Mycobacterium tuberculosis-induced cytotoxicity and induce anti-mycobacterial activity by a phagolysosome maturation-dependent mechanism in A549 type II alveolar epithelial cells.

Authors:  Emanuela Greco; Marilina B Santucci; Michela Sali; Francesca R De Angelis; Massimiliano Papi; Marco De Spirito; Giovanni Delogu; Vittorio Colizzi; Maurizio Fraziano
Journal:  Immunology       Date:  2009-06-22       Impact factor: 7.397

6.  Dectin-1 is inducible and plays an essential role for mycobacteria-induced innate immune responses in airway epithelial cells.

Authors:  Hye-Mi Lee; Jae-Min Yuk; Dong-Min Shin; Eun-Kyeong Jo
Journal:  J Clin Immunol       Date:  2009-07-25       Impact factor: 8.317

7.  IL-12+IL-18 Cosignaling in Human Macrophages and Lung Epithelial Cells Activates Cathelicidin and Autophagy, Inhibiting Intracellular Mycobacterial Growth.

Authors:  Rui Yang; Enzhuo Yang; Ling Shen; Robert L Modlin; Hongbo Shen; Zheng W Chen
Journal:  J Immunol       Date:  2018-02-16       Impact factor: 5.422

8.  Rifampin inhibits prostaglandin E2 production and arachidonic acid release in human alveolar epithelial cells.

Authors:  Yael Yuhas; Inbar Azoulay-Alfaguter; Eva Berent; Shai Ashkenazi
Journal:  Antimicrob Agents Chemother       Date:  2007-10-01       Impact factor: 5.191

9.  Roles of NF-kappaB activation and peroxisome proliferator-activated receptor gamma inhibition in the effect of rifampin on inducible nitric oxide synthase transcription in human lung epithelial cells.

Authors:  Yael Yuhas; Eva Berent; Regev Cohen; Shai Ashkenazi
Journal:  Antimicrob Agents Chemother       Date:  2008-12-29       Impact factor: 5.191

10.  The role of nitric oxide in mycobacterial infections.

Authors:  Chul-Su Yang; Jae-Min Yuk; Eun-Kyeong Jo
Journal:  Immune Netw       Date:  2009-04-30       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.